Article Text

other Versions

PDF
Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life
  1. Puneet Plaha,
  2. Shazia Javed,
  3. David Agombar,
  4. Genevive O' Farrell,
  5. Sadaquate Khan,
  6. Alan Whone,
  7. Steven Gill
  1. Institute of Neurosciences, Frenchay Hospital, Bristol, UK
  1. Correspondence to Professor Steven Gill, Department of Neurosurgery, Frenchay Hospital, Bristol BS16 1LE, UK; steven.gill{at}nbt.nhs.uk

Abstract

Background Over the past few years, bilateral stimulation of the caudal or motor part of the zona incerta nucleus (cZI) has been performed by the authors in patients with essential tremor (ET). Outcomes including quality of life data in 15 patients with a follow-up period of up to 84 months (mean 31.7±28.6 months) are presented.

Methods 15 consecutive ET patients underwent MRI guided bilateral cZI deep brain stimulation implantation. Patients were assessed by applying the Fahn–Tolosa–Marin Tremor Rating Scale and the Short Form Health Survey-36 (SF-36) to assess quality of life.

Results The total tremor score improved by 73.8% (p<0.0001). The part A score (items 1–9) improved by 86.6% (p<0.0001). Postural tremor improved by 88.2% (p<0.0001) and action tremor by 82.2% (p<0.0001). The part B score, which evaluates the functional activities of the upper limbs, improved by 60.1% (p<0.0001). Part C score, which evaluates the activities of daily living, improved by 80.0% (p<0.0001). The SF-36 physical component score improved by 23.7% (p<0.0001) and the mental component score by 22.4% (p<0.0001). There was one wound infection and three patients developed stimulation related transient dysarthria. None developed any disequilibrium or tolerance to stimulation.

Conclusion Bilateral cZI stimulation is safe and effective in suppressing the postural and action component of ET. It is associated with a low incidence of stimulation related complications and patients do not develop tolerance to stimulation with maintained clinical benefit over a follow-up period of up to 7 years.

Statistics from Altmetric.com

Footnotes

  • Funding PP was supported by a grant from the Medical Research Council UK (G9900797).

  • Competing interests SG and SJ are consultants with Renishaw Plc, UK.

  • Ethics approval This study was conducted with the approval of the Frenchay Hospital Ethics Committee, Bristol.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.